To learn more about our ongoing clinical trials or to find out if a trial is enrolling patients in your area, please visit www.clinicaltrials.gov.
| Candidates | Phase | Study Number | Study Title |
|---|---|---|---|
| BLU-5937 | Phase 3 | NCT05599191 | CALM-1 – Refractory Chronic Cough |
| BLU-5937 | Phase 3 | NCT05600777 | CALM-2 – Refractory Chronic Cough |
At this time, BELLUS’ investigational therapy is not available on an expanded access or right-to-try basis for new patients. In the event BELLUS decides to consider expanded access or right-to-try use, the Company will evaluate and respond to each request that it receives on a case-by-case basis. For more information on our investigational therapy and ongoing clinical trials, please visit bellushealth.com/pipeline/blu-5937 or clinicaltrials.gov.